Literature DB >> 19041824

Routine serum calcitonin measurement in the evaluation of thyroid nodules.

Rossella Elisei1.   

Abstract

Calcitonin (CT) is secreted mainly by parafollicular C cells. In normal subjects, serum CT (sCT) levels are low and barely detectable by commonly used assays. Increased sCT levels are highly suggestive of medullary thyroid carcinoma (MTC). Since the clinical manifestation of MTC is a thyroid nodule, either single or in the context of a multinodular goitre, the routine measurement of sCT in the evaluation of thyroid nodule(s) facilitates the diagnosis of MTC. sCT measurement is indeed more sensitive than cytology in finding MTC. There are two major benefits from this clinical practice: (a) the surgeon is alerted to the need to perform total thyroidectomy and central compartment lymphadenectomy, which is the minimal surgical treatment for MTC; and (b) the outcome of MTC is favourably affected because it is usually identified at a less advanced stage. However, other non-MTC causes of hypercalcitoninaemia and false sCT positivity do exist and must be recognized. The differential diagnosis is possible using previously validated assays against possible sources of interference, and performing stimulation tests with pentagastrin or, eventually, calcium infusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041824     DOI: 10.1016/j.beem.2008.09.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  16 in total

1.  Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases.

Authors:  Cléber P Camacho; Susan C Lindsey; Teresa S Kasamatsu; Alberto L Machado; João Roberto M Martins; Rosa Paula M Biscolla; Magnus R Dias da Silva; José Gilberto H Vieira; Rui M B Maciel
Journal:  Eur Thyroid J       Date:  2014-06-18

2.  2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.

Authors:  R Elisei; M Alevizaki; B Conte-Devolx; K Frank-Raue; V Leite; G R Williams
Journal:  Eur Thyroid J       Date:  2012-12-19

3.  Stimulated calcitonin cut-offs by different tests.

Authors:  Laura Fugazzola
Journal:  Eur Thyroid J       Date:  2013-01-16

4.  Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

Authors:  R Ciampi; C Romei; L Pieruzzi; A Tacito; E Molinaro; L Agate; V Bottici; F Casella; C Ugolini; G Materazzi; F Basolo; R Elisei
Journal:  J Endocrinol Invest       Date:  2016-08-17       Impact factor: 4.256

5.  Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma.

Authors:  Fabio Maino; Cristina Dalmiglio; Nicoletta Benenati; Michele Campanile; Tania Pilli; Raffaella Forleo; Lucia Brilli; Cristina Ciuoli; Silvia Cantara; Marco Capezzone; Alessandra Cartocci; Furio Pacini; Maria Grazia Castagna
Journal:  Eur Thyroid J       Date:  2020-10-12

Review 6.  Thyroid safety in patients treated with liraglutide.

Authors:  M Gallo
Journal:  J Endocrinol Invest       Date:  2013-02       Impact factor: 4.256

7.  Calcitonin Screening in Nodular Thyroid Disease: Is There a Definitive Answer?

Authors:  Catarina Silvestre; Joaquim Sampaio Matias; Helena Proença; Maria João Bugalho
Journal:  Eur Thyroid J       Date:  2018-12-05

Review 8.  Thyroid nodules in pediatrics: which ones can be left alone, which ones must be investigated, when and how.

Authors:  Andrea Corrias; Alessandro Mussa
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

9.  Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits.

Authors:  Daniel J Drucker; Steven I Sherman; Fred S Gorelick; Richard M Bergenstal; Robert S Sherwin; John B Buse
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

10.  Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association.

Authors:  Rossella Elisei; Cristina Romei
Journal:  Thyroid Res       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.